Vincerx Pharma 6M share Spot Secondary priced at 75c
PremiumThe FlyVincerx Pharma 6M share Spot Secondary priced at 75c
7M ago
Vincerx Pharma offers to sell common stock, amount not stated
Premium
The Fly
Vincerx Pharma offers to sell common stock, amount not stated
7M ago
Vincerx: progress for VIP236 and VIP943 for solid tumors presented at AACR
Premium
The Fly
Vincerx: progress for VIP236 and VIP943 for solid tumors presented at AACR
7M ago
Cantor biotech/biopharma analysts hold analyst/industry conference call
PremiumThe FlyCantor biotech/biopharma analysts hold analyst/industry conference call
12M ago
Cantor biotech/biopharma analysts hold analyst/industry conference call
Premium
The Fly
Cantor biotech/biopharma analysts hold analyst/industry conference call
12M ago
Vincerx Pharma reports Q3 EPS (46c), consensus (46c)
Premium
The Fly
Vincerx Pharma reports Q3 EPS (46c), consensus (46c)
12M ago
Vincerx Pharma expects cash to fund operations into late 2024
PremiumThe FlyVincerx Pharma expects cash to fund operations into late 2024
1y ago
Vincerx Pharma reports Q2 EPS (52c), consensus (60c)
Premium
The Fly
Vincerx Pharma reports Q2 EPS (52c), consensus (60c)
1y ago
Vincerx Pharma presents preclinical data on VIP924
Premium
The Fly
Vincerx Pharma presents preclinical data on VIP924
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100